PR11023

Safety and immunogenicity of pneumococcal protein vaccine (PPrV) in healthy adults, toddlers and infants in Bangladesh

Short Title PPR02
Protocol No PR11023
Status Completed
Keywords SAFETY, IMMUNOGENICITY, PNEUMOCOCCAL, PROTEIN, VACCINE
Center Vaccine Sciences
MDG(s) this protocol relates to
HPNSDP(s) this protocol relates to
PI Name W. Abdullah Brooks
Collaborating Institutes (370) Sanofi Pasteur, France
(373) Sanofi Pasteur, Singapore
Funding
Summary
‹ Search All Protocols Here